Jan Ohrstrom

Senior Advisor

Senior Executive with international experience in Biotechnology and Pharma. Management appointments in Large and Mid-Cap US/EU Biopharma companies. Proven track record with product approvals, financing, M&A and IPO. Part of the management Team that Roadshowed ZymoGenetics inc (Nasdaq: ZGEN) through Private Placement, IPO and follow-on offerings. Incorporated ProFibrix Inc in 2008, and as CEO in 2013 led ProFibrix through M&A with The Medicines Company after successful Phase 3 completion and product approvals in EU and US. Board appointments in private and public companies.

Independent Board Director of Polyganics BV
Chairman of the Board G-therapeutics
Chairman of the Board VarmX
Chairman of the Board Blaze Therapeutics Inc.

Snr VP The Medicines Company
CEO Profibrix BV
Board Director Avigen Inc
Exec VP Mediquest Therapeutics Inc
Snr VP ZymoGenetics Inc
Director Novo Nordisk A/s